Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A versus triamcinolone for hemiplegic shoulder pain after stroke
2011-004682-32Phase 2Active
- Sponsor
- Fondazione Giglio
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A, triamcinolone acetonide in hemiplegic shoulder pain (PHS), sponsored by Fondazione Giglio. Started Mar 2012; status: active.
02
Drugs
botulinum toxin type Atriamcinolone acetonide
03
Conditions
hemiplegic shoulder pain (PHS)
Beyond the preview
Go deeper on 2011-004682-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004682-32.